Sep 12, 2023 / 08:30PM GMT
Ananda Ghosh - H.C. Wainwright & Co., LLC - Analyst
Hi, good afternoon, everyone, and thank you for joining the H.C. Wainwright 25th Annual Global Investment Conference. My name is Ananda Ghosh, an associate at H.C. Wainwright. That said, I would like to welcome Gail Farfel, CEO of ProMIS Neurosciences; and Larry Altstiel, CMO of ProMIS Neurosciences.
Larry Altstiel - ProMIS Neurosciences Inc. - Chief Medical Officer
Thank you.
Gail Farfel - ProMIS Neurosciences Inc. - CEO & Director
Thank you, Anand. It's a pleasure to be here, and we thank the organizers for inviting us. My disclosures -- or our disclosures are contained here. ProMIS Neurosciences is a company developing next-generation antibodies for treatment of neurodegenerative diseases. We have a proprietary platform, a computational algorithm that allows us to predict how proteins can misfold and then design antibodies -- generate antibodies specific to toxic misfolded forms of these proteins.
Our lead compound, our lead candidate is PMN310,
ProMIS Neurosciences Inc at HC Wainwright Investment Conference - New York Transcript
Sep 13, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers